Search

everythinglearnresearchcommunity

for

Search:↓

HST and HST/F promote hair growth and may help treat alopecia.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

Graves' disease often causes skin issues, especially hyperpigmentation, which may be linked to treatments.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

The system can automatically identify different hair and scalp conditions using machine learning.

Good hair and scalp health indicate good overall health.

Low energy laser therapy effectively treats certain skin conditions and improves recovery time without side effects.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Hair loss from weight-loss treatments is usually temporary and reversible.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.